Compare Gilead Sciences, Inc. (GILD) vs Motorola Solutions Inc (MSI) Price & Performance

Gilead Sciences (GILD) trades at $133.30, up 2.51% today, with strong technical momentum above key support at $130. The company demonstrates robust fundamentals with a 30.99% net income margin and consistent earnings beats in recent quarters. Recent FDA and EC approvals for Trodelvy in metastatic triple-negative breast cancer highlight growth potential beyond its HIV franchise.

Outlook remains positive with a consensus price target of $152.83 offering 14.6% upside, though risks include patent expirations and competitive pressures. The stock presents a compelling opportunity driven by oncology expansion and strong cash flow generation, supported by overwhelming analyst bullish sentiment.

Motorola Solutions (MSI) trades at $411.88, down 0.44% on the day, with a bearish technical signal but strong fundamentals. The company reported Q1 2026 EPS of $3.37, beating estimates, and maintains robust profitability with a net margin of 17.61% and ROE of 99.88%. Recent developments include the $1.5 billion acquisition of D-Fend Solutions and expansion of AI tools for public safety, signaling growth in mission-critical ecosystems.

Outlook is positive driven by AI innovation and a $15.7 billion backlog, though high valuation multiples (P/E 32.84) and significant debt pose risks. Analysts are bullish with a consensus price target of $512.33, representing 24% upside, but investors should monitor integration of acquisitions and competitive pressures from peers like Axon.